Trial Profile
Effects of sitagliptin on daily glucose fluctuation in Japanese type 2 diabetic outpatients inadequately controlled with insulin therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2014
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Dec 2014 Status changed from recruiting to completed as reported by UMIN record.
- 19 Jan 2014 New trial record